Growth hormone supplementation improves implantation and pregnancy productivity rates for poor-prognosis patients undertaking IVF
In a sequential crossover study of IVF conducted from 2002 to 2006, growth hormone (GH) supplementation was assessed in poor-prognosis patients, categorized on the basis of past failure to conceive (mean 3.05 cycles) due to low response to high-dose stimulation (<3 metaphase II oocytes) or po...
| Main Authors: | , |
|---|---|
| Format: | Journal Article |
| Published: |
Elsevier Ltd
2010
|
| Online Access: | http://hdl.handle.net/20.500.11937/36460 |